Ms. Ma is a Senior Board executive with over 25 years of experience in investing, building, and scaling companies with a focus on innovative product launches in digital health, technology, and the new energy transition. Dr. Jiong Ma serves and served as a Board Director of LinkinVax, Aledia, Voxel8, Lo3 Energy, mc10, acquired by Medidata, Storiant, Fulham, Convey Computer, acquired by Micron Technology, Powervation, acquired by RHOM Semiconductor, Laser Light Engine and Carbonite, Inc., which went public via IPO in 2011 and was subsequently acquired by OpenText in 2019 for approximately $1.45 billion.

As a Partner at Braemar Energy Ventures ($600 million AUM), Ms. Ma focused on investments in the digitization of industry, resource efficiency, mobility, renewable energy infrastructure, and depth. She was on the firm’s investment committee and has led more than 15 investments in growth-stage companies with a focus on innovative product launches, as well as raising funding, negotiating and structuring investments, hiring management teams, and assembling boards.

Prior to this, she was with the Venture Capital Group at 3i, a global private equity firm ($17 billion AUM), where she led investments across multiple stages in Digital Health, TMT and Cleantech. Among them are TransMedics Group (Nasdaq: TMDX) and ImpactRx/Symphony Health Solutions, which was later acquired by PRA Health Sciences (Nasdaq:PRAH).

Preceding the Venture Capital Group at 3i, Ms. Ma held several senior positions at Lucent Technologies and Bell Labs. Her responsibilities included lead roles in product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Ms. Ma was also a founding team member of Onetta, a fiber networks company.

She has a PhD in Electrical and Computer Engineering from the University of Colorado at Boulder and an MS in Electrical Engineering from Worcester Polytechnic Institute. Ms. Ma is a Kauffman Fellow.